Kiana Ruch

GENEICD Founder, Kiana Ruch, plans to deliver the medical community accessible genomics advances. Ms. Ruch is leading the GENEICD Development Team toward a future of innovation and integration to produce faster diagnoses while minimizing laboratory waste.

Trained as a biologist, Kiana’s interests are centered on medical genetics. Her experience as a graduate-level Tutor of Pharmacology, Neuroanatomy, and Medical Genetics, as well as being employed as a Research Assistant under Dr.Yalda Shokoohinia bring a diverse scientific skillset.

In 2017, Kiana became an author of the Human Genome Project: annotating the Eugracillis Dot Gene; Contig17. Previous areas of research include Parkinson’s disease, habitat restoration population-level soil-microbial genomics, microbial susceptibility in wastewater management, rare congenital disease, and oncology. In 2018, Ms. Ruch presented her research at the Mayo Clinic, Rochester. This work introduced the utility potential of high-tech genomic software to identify sequence consistencies relative to the unknown molecular pathway causing Hypoplastic Left Heart Syndrome.

In 2020, Kiana was involved in the phytochemical review of Arum Palaestinum, a traditional medicinal plant. This oncological research analyzed novel phytochemical responses in vivo for Hep2, HeLa, HepG2, and MCF7 cell types via apoptosis, cell cycle inhibition, and toxicity. Her most recent (current) research endeavors involve designing genetic profiles to identify the specific mechanism of actions and therapeutic efficacy for nutraceuticals compounds.